Peter Schur
Overview
Explore the profile of Peter Schur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nilles E, Karlson E, Norman M, Gilboa T, Fischinger S, Atyeo C, et al.
J Appl Lab Med
. 2021 Jul;
6(6):1561-1570.
PMID: 34196711
Background: Serological testing provides a record of prior infection with SARS-CoV-2, but assay performance requires independent assessment. Methods: We evaluated 3 commercial (Roche Diagnostics pan-IG, and Epitope Diagnostics IgM and...
2.
Choi M, Cui J, Costenbader K, Rydzewski D, Bernhard L, Schur P
Lupus Sci Med
. 2020 Nov;
7(1).
PMID: 33154098
Objective: Given the increasing relevance of the ANA assay to classification of SLE and the uncertainty and variation surrounding different ANA assay performance, we compared the human epithelial type 2...
3.
Nilles E, Karlson E, Norman M, Gilboa T, Fischinger S, Atyeo C, et al.
medRxiv
. 2020 Jul;
PMID: 32607518
Background Seroepidemiology is an important tool to characterize the epidemiology and immunobiology of SARS-CoV-2 but many immunoassays have not been externally validated raising questions about reliability of study findings. To...
4.
Lazaridou A, Kim J, Cahalan C, Loggia M, Franceschelli O, Berna C, et al.
Clin J Pain
. 2016 Aug;
33(3):215-221.
PMID: 27518491
Objective(s): Fibromyalgia (FM) is a chronic, common pain disorder characterized by hyperalgesia. A key mechanism by which cognitive-behavioral therapy (CBT) fosters improvement in pain outcomes is via reductions in hyperalgesia...
5.
Nambudiri V, Newman L, Haynes H, Schur P, Vleugels R
Acad Med
. 2014 Jan;
89(3):404-9.
PMID: 24448033
Few medical school electives include longitudinal patient care across clinical specialties and environments. Systemic lupus erythematosus represents a disease process with complex pathophysiology for students to learn from providers across...
6.
Merola J, Prystowsky S, Iversen C, Gomez-Puerta J, Norton T, Tsao P, et al.
J Am Acad Dermatol
. 2013 Apr;
69(1):19-24.
PMID: 23541758
Background: Cutaneous discoid lupus erythematosus (DLE) among patients with systemic lupus erythematosus (SLE) may be associated with less severe disease and with low frequency of nephritis and end-stage renal disease...
7.
Liao K, Kurreeman F, Li G, Duclos G, Murphy S, Guzman R, et al.
Arthritis Rheum
. 2012 Dec;
65(3):571-81.
PMID: 23233247
Objective: The significance of non-rheumatoid arthritis (RA) autoantibodies in patients with RA is unclear. The aim of this study was to assess associations of autoantibodies with autoimmune risk alleles and...
8.
Costenbader K, Khamashta M, Ruiz-Garcia S, Perez-Rodriguez M, Petri M, Elliott J, et al.
Arthritis Care Res (Hoboken)
. 2010 Apr;
62(4):559-68.
PMID: 20391512
Objective: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) is a validated instrument for assessing organ damage in systemic lupus erythematosus (SLE). Trained physicians must complete...
9.
Crispin J, Keenan B, Finnell M, Bermas B, Schur P, Massarotti E, et al.
Arthritis Rheum
. 2010 Mar;
62(5):1431-7.
PMID: 20213807
Objective: To quantify the expression of CD44 and variant isoforms CD44v3 and CD44v6 on T cells from patients with systemic lupus erythematosus (SLE), and to assess correlations of the level...
10.
Anderson R, Liang M, Schur P
Arthritis Rheum
. 2002 Feb;
42(6):1087.
PMID: 11857237
No abstract available.